TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1256328
log Bayes Factor = 11.6088
Chromosome 1   position 21,896,767  (GRCh37) Explore rs1256328 on Ensembl!
Variant rs1256328 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
N20.1 Calculus of ureter
1.000 0.000 0.000
N20.0 Calculus of kidney
1.000 0.000 0.000
N20 Calculus of kidney and ureter
1.000 0.000 0.000
N20.2 Calculus of kidney with calculus of ureter
0.992 0.008 0.000
N20.9 Urinary calculus, unspecified
0.940 0.060 0.000
N20-N23 Urolithiasis
0.827 0.173 0.000
N23 Unspecified renal colic
0.776 0.224 0.000
N21 Calculus of lower urinary tract
0.664 0.336 0.000
N22 Calculus of urinary tract in diseases classified elsewhere
0.593 0.407 0.000
N21.0 Calculus in bladder
0.563 0.437 0.000
N21.1 Calculus in urethra
0.510 0.489 0.000
N21.9 Calculus of lower urinary tract, unspecified
0.476 0.523 0.000
N22.8 Calculus of urinary tract in other diseases classified elsewhere
0.425 0.575 0.000
N22.0 Calculus of urinary tract in schistosomiasis [bilharziasis]
0.425 0.575 0.000
N21.8 Other lower urinary tract calculus
0.400 0.599 0.000
H53.0 Amblyopia ex anopsia
0.049 0.951 0.000
N13.2 Hydronephrosis with renal and ureteral calculous obstruction
0.045 0.955 0.000
N73.6 Female pelvic peritoneal adhesions
0.000 0.981 0.019
H91.9 Hearing loss, unspecified
0.000 0.985 0.015
N13 Obstructive and reflux uropathy
0.015 0.985 0.000
N13.4 Hydroureter
0.013 0.987 0.000
N13.3 Other and unspecified hydronephrosis
0.013 0.987 0.000
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk
0.000 0.988 0.012
H53 Visual disturbances
0.012 0.988 0.000
N10-N16 Renal tubulo-interstitial diseases
0.012 0.988 0.000
M25.77 Osteophyte (Ankle and foot)
0.000 0.989 0.011
N13.0 Hydronephrosis with ureteropelvic junction obstruction
0.011 0.989 0.000
G35 Multiple sclerosis
0.000 0.990 0.010
N13.7 Vesicoureteral-reflux-associated uropathy
0.010 0.990 0.000
N13.6 Pyonephrosis
0.010 0.990 0.000
H53.8 Other visual disturbances
0.010 0.990 0.000
N48.8 Other specified disorders of penis
0.009 0.991 0.000
N15 Other renal tubulo-interstitial diseases
0.009 0.991 0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified
0.009 0.991 0.000
N10 Acute tubulo-interstitial nephritis
0.009 0.991 0.000
H53.4 Visual field defects
0.009 0.991 0.000
N11 Chronic tubulo-interstitial nephritis
0.009 0.991 0.000
H53.6 Night blindness
0.009 0.991 0.000
H53.5 Colour vision deficiencies
0.009 0.991 0.000
H53.3 Other disorders of binocular vision
0.009 0.991 0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere
0.009 0.991 0.000
H53.9 Visual disturbance, unspecified
0.009 0.991 0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic
0.009 0.991 0.000
Chapter XIV Diseases of the genitourinary system
0.009 0.991 0.000
D21.2 Connective and other soft tissue of lower limb, including hip
0.009 0.991 0.000
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions
0.008 0.992 0.000
N73 Other female pelvic inflammatory diseases
0.001 0.992 0.007
N15.9 Renal tubulo-interstitial disease, unspecified
0.008 0.992 0.000
N13.8 Other obstructive and reflux uropathy
0.007 0.993 0.000
H91 Other hearing loss
0.000 0.993 0.007
N15.8 Other specified renal tubulo-interstitial diseases
0.007 0.993 0.000
N15.0 Balkan nephropathy
0.007 0.993 0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified
0.007 0.993 0.000
N13.5 Kinking and stricture of ureter without hydronephrosis
0.007 0.993 0.000
Y44.2 Anticoagulants
0.007 0.993 0.000
N11.8 Other chronic tubulo-interstitial nephritis
0.006 0.993 0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis
0.006 0.993 0.000
N15.1 Renal and perinephric abscess
0.006 0.993 0.000
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere
0.006 0.993 0.000
N16.5 Renal tubulo-interstitial disorders in transplant rejection
0.006 0.993 0.000
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders
0.006 0.993 0.000
N16.3 Renal tubulo-interstitial disorders in metabolic diseases
0.006 0.993 0.000
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism
0.006 0.993 0.000
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases
0.006 0.993 0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere
0.006 0.993 0.000
N11.1 Chronic obstructive pyelonephritis
0.006 0.994 0.000
N14.4 Toxic nephropathy, not elsewhere classified
0.006 0.994 0.000
N14.3 Nephropathy induced by heavy metals
0.006 0.994 0.000
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance
0.006 0.994 0.000
N14.0 Analgesic nephropathy
0.006 0.994 0.000
N13.9 Obstructive and reflux uropathy, unspecified
0.006 0.994 0.000
R12 Heartburn
0.000 0.994 0.006
H53.1 Subjective visual disturbances
0.006 0.994 0.000
N73.8 Other specified female pelvic inflammatory diseases
0.001 0.994 0.005
N73.5 Female pelvic peritonitis, unspecified
0.001 0.994 0.005
N73.4 Female chronic pelvic peritonitis
0.001 0.994 0.005
N73.3 Female acute pelvic peritonitis
0.001 0.994 0.005
N73.2 Unspecified parametritis and pelvic cellulitis
0.001 0.994 0.005
K75.9 Inflammatory liver disease, unspecified
0.000 0.994 0.006
N08 Glomerular disorders in diseases classified elsewhere
0.006 0.994 0.000
N73.1 Chronic parametritis and pelvic cellulitis
0.001 0.994 0.005
N00-N08 Glomerular diseases
0.006 0.994 0.000
N73.0 Acute parametritis and pelvic cellulitis
0.001 0.994 0.005
N08.3 Glomerular disorders in diabetes mellitus
0.006 0.994 0.000
N14.1 Nephropathy induced by other drugs, medicaments and biological substances
0.005 0.994 0.000
T31.0 Burns involving less than 10% of body surface
0.006 0.994 0.000
N25-N29 Other disorders of kidney and ureter
0.005 0.995 0.000
H91.2 Sudden idiopathic hearing loss
0.000 0.995 0.005
H91.0 Ototoxic hearing loss
0.000 0.995 0.005
N73.9 Female pelvic inflammatory disease, unspecified
0.000 0.995 0.005
N08.5 Glomerular disorders in systemic connective tissue disorders
0.005 0.995 0.000
H90.2 Conductive hearing loss, unspecified
0.000 0.995 0.005
N99-N99 Other disorders of the genitourinary system
0.005 0.995 0.000
H91.8 Other specified hearing loss
0.000 0.995 0.005
H91.3 Deaf mutism, not elsewhere classified
0.000 0.995 0.005
Y44 Agents primarily affecting blood constituents
0.005 0.995 0.000
H91.1 Presbycusis
0.000 0.995 0.005
N29 Other disorders of kidney and ureter in diseases classified elsewhere
0.005 0.995 0.000
N48.0 Leukoplakia of penis
0.005 0.995 0.000
M84.03 Malunion of fracture (Forearm)
0.000 0.995 0.005
N48 Other disorders of penis
0.005 0.995 0.000
N08.8 Glomerular disorders in other diseases classified elsewhere
0.004 0.995 0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases
0.004 0.995 0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism
0.004 0.995 0.000
N08.1 Glomerular disorders in neoplastic diseases
0.004 0.995 0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere
0.004 0.995 0.000
H66.9 Otitis media, unspecified
0.000 0.996 0.004
N07 Hereditary nephropathy, not elsewhere classified
0.004 0.996 0.000
N06 Isolated proteinuria with specified morphological lesion
0.004 0.996 0.000
N01 Rapidly progressive nephritic syndrome
0.004 0.996 0.000
N00 Acute nephritic syndrome
0.004 0.996 0.000
N25 Disorders resulting from impaired renal tubular function
0.004 0.996 0.000
N76 Other inflammation of vagina and vulva
0.004 0.996 0.000
N29.8 Other disorders of kidney and ureter in other diseases classified elsewhere
0.004 0.996 0.000
N48.9 Disorder of penis, unspecified
0.004 0.996 0.000
N95.2 Postmenopausal atrophic vaginitis
0.000 0.996 0.004
N27 Small kidney of unknown cause
0.004 0.996 0.000
Y44.5 Thrombolytic drugs
0.004 0.996 0.000
H90 Conductive and sensorineural hearing loss
0.000 0.996 0.004
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.004 0.996 0.000
Z11.2 Special screening examination for other bacterial diseases
0.004 0.996 0.000
N76.5 Ulceration of vagina
0.004 0.996 0.000
N04 Nephrotic syndrome
0.004 0.996 0.000
G81.9 Hemiplegia, unspecified
0.004 0.996 0.000
N70-N77 Inflammatory diseases of female pelvic organs
0.003 0.996 0.001
N76.4 Abscess of vulva
0.004 0.996 0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.996 0.004
H90.0 Conductive hearing loss, bilateral
0.000 0.996 0.004
K14.0 Glossitis
0.004 0.996 0.000
D21 Other benign neoplasms of connective and other soft tissue
0.004 0.996 0.000
N76.6 Ulceration of vulva
0.004 0.996 0.000
N76.0 Acute vaginitis
0.004 0.996 0.000
N76.2 Acute vulvitis
0.004 0.996 0.000
C18.2 Ascending colon
0.000 0.996 0.004
N48.5 Ulcer of penis
0.004 0.996 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.004 0.996 0.000
Y44.7 Plasma substitutes
0.004 0.996 0.000
Y44.6 Natural blood and blood products
0.004 0.996 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.004 0.996 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.004 0.996 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.004 0.996 0.000
N26 Unspecified contracted kidney
0.004 0.996 0.000
N29.1 Other disorders of kidney and ureter in infectious and parasitic diseases classified elsewhere
0.003 0.996 0.000
N29.0 Late syphilis of kidney
0.003 0.996 0.000
H53-H54 Visual disturbances and blindness
0.004 0.996 0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral
0.000 0.996 0.004
N25.8 Other disorders resulting from impaired renal tubular function
0.003 0.996 0.000
N48.3 Priapism
0.003 0.996 0.000
H90-H95 Other disorders of ear
0.000 0.996 0.003
D21.5 Connective and other soft tissue of pelvis
0.003 0.996 0.000
N00.9 Unspecified
0.003 0.997 0.000
N00.8 Other
0.003 0.997 0.000
N00.7 Diffuse crescentic glomerulonephritis
0.003 0.997 0.000
N00.6 Dense deposit disease
0.003 0.997 0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis
0.003 0.997 0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis
0.003 0.997 0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis
0.003 0.997 0.000
N00.2 Diffuse membranous glomerulonephritis
0.003 0.997 0.000
N00.1 Focal and segmental glomerular lesions
0.003 0.997 0.000
N00.0 Minor glomerular abnormality
0.003 0.997 0.000
N01.9 Unspecified
0.003 0.997 0.000
N01.8 Other
0.003 0.997 0.000
N01.7 Diffuse crescentic glomerulonephritis
0.003 0.997 0.000
N01.6 Dense deposit disease
0.003 0.997 0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis
0.003 0.997 0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis
0.003 0.997 0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis
0.003 0.997 0.000
N01.2 Diffuse membranous glomerulonephritis
0.003 0.997 0.000
N01.1 Focal and segmental glomerular lesions
0.003 0.997 0.000
N01.0 Minor glomerular abnormality
0.003 0.997 0.000
N06.9 Unspecified
0.003 0.997 0.000
N06.8 Other
0.003 0.997 0.000
N06.7 Diffuse crescentic glomerulonephritis
0.003 0.997 0.000
N06.6 Dense deposit disease
0.003 0.997 0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis
0.003 0.997 0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis
0.003 0.997 0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis
0.003 0.997 0.000
N06.2 Diffuse membranous glomerulonephritis
0.003 0.997 0.000
N06.1 Focal and segmental glomerular lesions
0.003 0.997 0.000
N06.0 Minor glomerular abnormality
0.003 0.997 0.000
N07.9 Unspecified
0.003 0.997 0.000
N07.8 Other
0.003 0.997 0.000
N07.7 Diffuse crescentic glomerulonephritis
0.003 0.997 0.000
N07.6 Dense deposit disease
0.003 0.997 0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis
0.003 0.997 0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis
0.003 0.997 0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis
0.003 0.997 0.000
N07.2 Diffuse membranous glomerulonephritis
0.003 0.997 0.000
N07.1 Focal and segmental glomerular lesions
0.003 0.997 0.000
N07.0 Minor glomerular abnormality
0.003 0.997 0.000
N25.9 Disorder resulting from impaired renal tubular function, unspecified
0.003 0.997 0.000
N25.1 Nephrogenic diabetes insipidus
0.003 0.997 0.000
N25.0 Renal osteodystrophy
0.003 0.997 0.000
N76.1 Subacute and chronic vaginitis
0.003 0.997 0.000
N27.0 Small kidney, unilateral
0.003 0.997 0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder
0.003 0.997 0.000
N03 Chronic nephritic syndrome
0.003 0.997 0.000
N27.9 Small kidney, unspecified
0.003 0.997 0.000
N27.1 Small kidney, bilateral
0.003 0.997 0.000
G35-G37 Demyelinating diseases of the central nervous system
0.000 0.997 0.003
N05 Unspecified nephritic syndrome
0.003 0.997 0.000
N02 Recurrent and persistent haematuria
0.003 0.997 0.000
Z11.0 Special screening examination for intestinal infectious diseases
0.003 0.997 0.000
N04.8 Other
0.003 0.997 0.000
N04.7 Diffuse crescentic glomerulonephritis
0.003 0.997 0.000
N04.6 Dense deposit disease
0.003 0.997 0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.003 0.997 0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.003 0.997 0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.003 0.997 0.000
N04.2 Diffuse membranous glomerulonephritis
0.003 0.997 0.000
N04.1 Focal and segmental glomerular lesions
0.003 0.997 0.000
N04.0 Minor glomerular abnormality
0.003 0.997 0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere
0.003 0.997 0.000
T31 Burns classified according to extent of body surface involved
0.003 0.997 0.000
D21.4 Connective and other soft tissue of abdomen
0.003 0.997 0.000
N76.3 Subacute and chronic vulvitis
0.003 0.997 0.000
N74 Female pelvic inflammatory disorders in diseases classified elsewhere
0.003 0.997 0.001
S46.0 Injury of tendon of the rotator cuff of shoulder
0.003 0.997 0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified
0.000 0.997 0.003
N70 Salpingitis and oophoritis
0.003 0.997 0.001
D21.6 Connective and other soft tissue of trunk, unspecified
0.003 0.997 0.000
D21.3 Connective and other soft tissue of thorax
0.003 0.997 0.000
D21.9 Connective and other soft tissue, unspecified
0.003 0.997 0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.997 0.003
X62.9 Unspecified place
0.003 0.997 0.000
Y52.1 Calcium-channel blockers
0.003 0.997 0.000
H90.3 Sensorineural hearing loss, bilateral
0.000 0.997 0.003
Z73.8 Other problems related to life-management difficulty
0.003 0.997 0.000
N40-N51 Diseases of male genital organs
0.003 0.997 0.000
N41 Inflammatory diseases of prostate
0.003 0.997 0.000
Z11 Special screening examination for infectious and parasitic diseases
0.003 0.997 0.000
N41.0 Acute prostatitis
0.003 0.997 0.000
N04.9 Unspecified
0.003 0.997 0.000
N48.2 Other inflammatory disorders of penis
0.003 0.997 0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.003 0.997 0.000
H94 Other disorders of ear in diseases classified elsewhere
0.000 0.997 0.003
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.997 0.003
N76.8 Other specified inflammation of vagina and vulva
0.003 0.997 0.000
G81 Hemiplegia
0.003 0.997 0.000
N48.1 Balanoposthitis
0.003 0.997 0.000
N70.1 Chronic salpingitis and oophoritis
0.003 0.997 0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified
0.000 0.997 0.003
G81.1 Spastic hemiplegia
0.003 0.997 0.000
N03.8 Other
0.003 0.997 0.000
N03.7 Diffuse crescentic glomerulonephritis
0.003 0.997 0.000
N03.6 Dense deposit disease
0.003 0.997 0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis
0.003 0.997 0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis
0.003 0.997 0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis
0.003 0.997 0.000
N03.2 Diffuse membranous glomerulonephritis
0.003 0.997 0.000
N03.1 Focal and segmental glomerular lesions
0.003 0.997 0.000
N03.0 Minor glomerular abnormality
0.003 0.997 0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
0.002 0.997 0.000
N02.7 Diffuse crescentic glomerulonephritis
0.002 0.997 0.000
N02.6 Dense deposit disease
0.002 0.997 0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis
0.002 0.997 0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis
0.002 0.997 0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis
0.002 0.997 0.000
N02.1 Focal and segmental glomerular lesions
0.002 0.997 0.000
N02.0 Minor glomerular abnormality
0.002 0.997 0.000
G36 Other acute disseminated demyelination
0.000 0.997 0.002
N05.7 Diffuse crescentic glomerulonephritis
0.002 0.997 0.000
N05.6 Dense deposit disease
0.002 0.997 0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.002 0.997 0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.002 0.997 0.000
N05.0 Minor glomerular abnormality
0.002 0.997 0.000
N99.5 Malfunction of external stoma of urinary tract
0.003 0.997 0.000
N51 Disorders of male genital organs in diseases classified elsewhere
0.003 0.997 0.000
T31.9 Burns involving 90% or more of body surface
0.002 0.997 0.000
T31.8 Burns involving 80-89% of body surface
0.002 0.997 0.000
T31.7 Burns involving 70-79% of body surface
0.002 0.997 0.000
T31.6 Burns involving 60-69% of body surface
0.002 0.997 0.000
T31.5 Burns involving 50-59% of body surface
0.002 0.997 0.000
T31.4 Burns involving 40-49% of body surface
0.002 0.997 0.000
T31.3 Burns involving 30-39% of body surface
0.002 0.997 0.000
T31.2 Burns involving 20-29% of body surface
0.002 0.997 0.000
T31.1 Burns involving 10-19% of body surface
0.002 0.997 0.000
Y52 Agents primarily affecting the cardiovascular system
0.003 0.997 0.000
N41.9 Inflammatory disease of prostate, unspecified
0.003 0.997 0.000
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere
0.002 0.997 0.000
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere
0.002 0.997 0.000
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters
0.000 0.997 0.003
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified
0.003 0.997 0.000
H66 Suppurative and unspecified otitis media
0.000 0.997 0.003
S42.20 Fracture of upper end of humerus (closed)
0.000 0.997 0.003
N02.2 Diffuse membranous glomerulonephritis
0.002 0.997 0.000
N41.8 Other inflammatory diseases of prostate
0.002 0.997 0.000
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere
0.002 0.997 0.001
N74.4 Female chlamydial pelvic inflammatory disease
0.002 0.997 0.001
N74.3 Female gonococcal pelvic inflammatory disease
0.002 0.997 0.001
N74.2 Female syphilitic pelvic inflammatory disease
0.002 0.997 0.001
N74.1 Female tuberculous pelvic inflammatory disease
0.002 0.997 0.001
N74.0 Tuberculous infection of cervix uteri
0.002 0.997 0.001
H66.3 Other chronic suppurative otitis media
0.000 0.997 0.002
N46 Male infertility
0.002 0.997 0.000
M43.16 Spondylolisthesis (Lumbar region)
0.000 0.998 0.002
Z11.8 Special screening examination for other infectious and parasitic diseases
0.002 0.998 0.000
K14 Diseases of tongue
0.002 0.998 0.000
N70.0 Acute salpingitis and oophoritis
0.002 0.998 0.001
Z53.2 Procedure not carried out because of patient's decision for other and unspecified reasons
0.002 0.998 0.000
N02.8 Other
0.002 0.998 0.000
N71 Inflammatory disease of uterus, except cervix
0.002 0.998 0.001
W10.8 Other specified place
0.002 0.998 0.000
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure
0.002 0.998 0.000
N05.1 Focal and segmental glomerular lesions
0.002 0.998 0.000
N51.2 Balanitis in diseases classified elsewhere
0.002 0.998 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.002 0.998 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.002 0.998 0.000
N44 Torsion of testis
0.002 0.998 0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.002 0.998 0.000
L02 Cutaneous abscess, furuncle and carbuncle
0.000 0.998 0.002
N39.4 Other specified urinary incontinence
0.002 0.998 0.000
N48.4 Impotence of organic origin
0.002 0.998 0.000
N41.3 Prostatocystitis
0.002 0.998 0.000
N41.2 Abscess of prostate
0.002 0.998 0.000
K14.8 Other diseases of tongue
0.002 0.998 0.000
N05.8 Other
0.002 0.998 0.000
N05.2 Diffuse membranous glomerulonephritis
0.002 0.998 0.000
Z11.6 Special screening examination for other protozoal diseases and helminthiases
0.002 0.998 0.000
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission
0.002 0.998 0.000
Z11.1 Special screening examination for respiratory tuberculosis
0.002 0.998 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.002 0.998 0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity
0.000 0.998 0.002
R47.0 Dysphasia and aphasia
0.002 0.998 0.000
Z11.4 Special screening examination for human immunodeficiency virus [HIV]
0.002 0.998 0.000
Z73.9 Problem related to life-management difficulty, unspecified
0.002 0.998 0.000
H20.0 Acute and subacute iridocyclitis
0.002 0.998 0.000
H94.8 Other specified disorders of ear in diseases classified elsewhere
0.000 0.998 0.002
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere
0.000 0.998 0.002
N99.1 Postprocedural urethral stricture
0.002 0.998 0.000
S05.1 Contusion of eyeball and orbital tissues
0.002 0.998 0.000
Z11.5 Special screening examination for other viral diseases
0.002 0.998 0.000
S82.50 Fracture of medial malleolus (closed)
0.002 0.998 0.000
S46.2 Injury of muscle and tendon of other parts of biceps
0.002 0.998 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.002 0.998 0.000
G81.0 Flaccid hemiplegia
0.002 0.998 0.000
V49.6 Unspecified car occupant injured in collision with other and unspecified motor vehicles in traffic accident
0.002 0.998 0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified
0.000 0.998 0.002
H95.8 Other postprocedural disorders of ear and mastoid process
0.000 0.998 0.002
N99.2 Postprocedural adhesions of vagina
0.002 0.998 0.000
N64.9 Disorder of breast, unspecified
0.002 0.998 0.000
S46 Injury of muscle and tendon at shoulder and upper arm level
0.002 0.998 0.000
V49 Car occupant injured in other and unspecified transport accidents
0.002 0.998 0.000
D16.4 Bones of skull and face
0.002 0.998 0.000
G36.9 Acute disseminated demyelination, unspecified
0.000 0.998 0.002
G36.8 Other specified acute disseminated demyelination
0.000 0.998 0.002
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.000 0.998 0.002
G36.0 Neuromyelitis optica [Devic]
0.000 0.998 0.002
N05.9 Unspecified
0.002 0.998 0.000
H53.2 Diplopia
0.002 0.998 0.000
K14.6 Glossodynia
0.002 0.998 0.000
N51.8 Other disorders of male genital organs in diseases classified elsewhere
0.002 0.998 0.000
N51.1 Disorders of testis and epididymis in diseases classified elsewhere
0.002 0.998 0.000
N51.0 Disorders of prostate in diseases classified elsewhere
0.002 0.998 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.002 0.998 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.002 0.998 0.000
Y52.7 Peripheral vasodilators
0.002 0.998 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.002 0.998 0.000
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified
0.002 0.998 0.000
N99.9 Postprocedural disorder of genito-urinary system, unspecified
0.002 0.998 0.000
H66.2 Chronic atticoantral suppurative otitis media
0.000 0.998 0.002
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident
0.002 0.998 0.000
H66.1 Chronic tubotympanic suppurative otitis media
0.000 0.998 0.002
I63.9 Cerebral infarction, unspecified
0.002 0.998 0.000
L02.0 Cutaneous abscess, furuncle and carbuncle of face
0.000 0.998 0.002
H93 Other disorders of ear, not elsewhere classified
0.000 0.998 0.002
D21.0 Connective and other soft tissue of head, face and neck
0.001 0.998 0.001
K14.5 Plicated tongue
0.002 0.998 0.000
K14.4 Atrophy of tongue papillae
0.002 0.998 0.000
K14.3 Hypertrophy of tongue papillae
0.002 0.998 0.000
K14.2 Median rhomboid glossitis
0.002 0.998 0.000
K14.1 Geographic tongue
0.002 0.998 0.000
G37 Other demyelinating diseases of central nervous system
0.000 0.998 0.002
G95.9 Disease of spinal cord, unspecified
0.000 0.998 0.002
N71.0 Acute inflammatory disease of uterus
0.002 0.998 0.001
H54 Blindness and low vision
0.002 0.998 0.000
K14.9 Disease of tongue, unspecified
0.002 0.998 0.000
X62.0 Home
0.002 0.998 0.000
X62.8 Other specified place
0.002 0.998 0.000
X62.7 Farm
0.002 0.998 0.000
X62.6 Industrial and construction area
0.002 0.998 0.000
X62.5 Trade and service area
0.002 0.998 0.000
X62.4 Street and highway
0.002 0.998 0.000
X62.3 Sports and athletics area
0.002 0.998 0.000
X62.2 School, other institution and public administrative area
0.002 0.998 0.000
X62.1 Residential institution
0.002 0.998 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.002 0.998 0.000
H20.1 Chronic iridocyclitis
0.002 0.998 0.000
H66.0 Acute suppurative otitis media
0.000 0.998 0.002
X63.0 Home
0.002 0.998 0.000
Z73 Problems related to life-management difficulty
0.002 0.998 0.000
H66.4 Suppurative otitis media, unspecified
0.000 0.998 0.002
M84.0 Malunion of fracture
0.000 0.998 0.002
Y42.7 Androgens and anabolic congeners
0.002 0.998 0.000
H20 Iridocyclitis
0.002 0.998 0.000
M81.90 Osteoporosis, unspecified (Multiple sites)
0.000 0.998 0.002
H95.1 Other disorders following mastoidectomy
0.000 0.998 0.002
I20.8 Other forms of angina pectoris
0.002 0.998 0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system
0.002 0.998 0.000
X60-X84 Intentional self-harm
0.002 0.998 0.000
A49.0 Staphylococcal infection, unspecified
0.000 0.998 0.002
D25.9 Leiomyoma of uterus, unspecified
0.000 0.998 0.002
S46.1 Injury of muscle and tendon of long head of biceps
0.002 0.998 0.000
V49.9 Car occupant [any] injured in unspecified traffic accident
0.002 0.998 0.000
N99.8 Other postprocedural disorders of genito-urinary system
0.002 0.998 0.000
S46.8 Injury of other muscles and tendons at shoulder and upper arm level
0.002 0.998 0.000
U80.1 Methicillin resistant agent
0.000 0.998 0.002
Y88 Sequelae of surgical and medical care as external cause
0.002 0.998 0.000
V40-V49 Car occupant injured in transport accident
0.002 0.998 0.000
H02.9 Disorder of eyelid, unspecified
0.000 0.998 0.002
H54.6 Unqualified visual loss, one eye
0.002 0.998 0.000
N41.1 Chronic prostatitis
0.002 0.998 0.000
N70.9 Salpingitis and oophoritis, unspecified
0.001 0.998 0.001
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites
0.000 0.998 0.002
S46.9 Injury of unspecified muscle and tendon at shoulder and upper arm level
0.002 0.998 0.000
S46.7 Injury of multiple muscles and tendons at shoulder and upper arm level
0.002 0.998 0.000
S46.3 Injury of muscle and tendon of triceps
0.002 0.998 0.000
V49.8 Car occupant [any] injured in other specified transport accidents
0.002 0.998 0.000
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident
0.002 0.998 0.000
V49.3 Car occupant [any] injured in unspecified nontraffic accident
0.002 0.998 0.000
V49.2 Unspecified car occupant injured in collision with other and unspecified motor vehicles in nontraffic accident
0.002 0.998 0.000
V49.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident
0.002 0.998 0.000
V49.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident
0.002 0.998 0.000
Y46.4 Iminostilbenes
0.002 0.998 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.002 0.998 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.002 0.998 0.000
H20.9 Iridocyclitis, unspecified
0.002 0.998 0.000
K25.4 Chronic or unspecified with haemorrhage
0.000 0.998 0.002
C18.6 Descending colon
0.002 0.998 0.000
H54.2 Low vision, both eyes
0.002 0.998 0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified
0.000 0.998 0.002
N02.9 Unspecified
0.002 0.998 0.000
X59.2 School, other institution and public administrative area
0.002 0.998 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck
0.000 0.998 0.002
R49.0 Dysphonia
0.002 0.998 0.000
X59 Exposure to unspecified factor
0.002 0.998 0.000
N99.0 Postprocedural renal failure
0.002 0.998 0.000
N49 Inflammatory disorders of male genital organs, not elsewhere classified
0.002 0.998 0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
0.002 0.998 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.002 0.998 0.000
H93.2 Other abnormal auditory perceptions
0.000 0.998 0.002
H93.0 Degenerative and vascular disorders of ear
0.000 0.998 0.002
K43.9 Ventral hernia without obstruction or gangrene
0.000 0.998 0.002
Y46.6 Other and unspecified antiepileptics
0.002 0.998 0.000
N28 Other disorders of kidney and ureter, not elsewhere classified
0.002 0.998 0.000
G37.8 Other specified demyelinating diseases of central nervous system
0.000 0.998 0.002
G37.5 Concentric sclerosis [Balo]
0.000 0.998 0.002
G37.4 Subacute necrotising myelitis
0.000 0.998 0.002
G37.2 Central pontine myelinolysis
0.000 0.998 0.002
G37.1 Central demyelination of corpus callosum
0.000 0.998 0.002
G37.0 Diffuse sclerosis
0.000 0.998 0.002
N71.1 Chronic inflammatory disease of uterus
0.001 0.998 0.001
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.002 0.998 0.000
Z73.6 Limitation of activities due to disability
0.002 0.998 0.000
S52.10 Fracture of upper end of radius (closed)
0.002 0.998 0.000
H54.3 Unqualified visual loss, both eyes
0.002 0.998 0.000
H54.1 Blindness, one eye, low vision, other eye
0.002 0.998 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.002 0.998 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.002 0.998 0.000
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity
0.001 0.998 0.000
D16.1 Short bones of upper limb
0.002 0.998 0.000
H93.1 Tinnitus
0.000 0.998 0.002
M84.09 Malunion of fracture (Site unspecified)
0.000 0.998 0.002
M84.08 Malunion of fracture (Other)
0.000 0.998 0.002
M84.02 Malunion of fracture (Upper arm)
0.000 0.998 0.002
M84.00 Malunion of fracture (Multiple sites)
0.000 0.998 0.002
N90.8 Other specified noninflammatory disorders of vulva and perineum
0.000 0.998 0.002
Z73.5 Social role conflict, not elsewhere classified
0.002 0.998 0.000
Z73.4 Inadequate social skills, not elsewhere classified
0.002 0.998 0.000
Z73.2 Lack of relaxation and leisure
0.002 0.998 0.000
Z73.1 Accentuation of personality traits
0.002 0.998 0.000
Z73.0 Burn-out
0.002 0.998 0.000
N47 Redundant prepuce, phimosis and paraphimosis
0.002 0.998 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.002 0.998 0.000
M84.01 Malunion of fracture (Shoulder region)
0.000 0.998 0.002
D11.0 Parotid gland
0.000 0.998 0.002
H20.2 Lens-induced iridocyclitis
0.002 0.998 0.000
H54.9 Unspecified visual impairment (binocular)
0.002 0.998 0.000
X59.3 Sports and athletics area
0.002 0.998 0.000
Y53.4 Other laxatives
0.002 0.998 0.000
Y88.1 Sequelae of misadventures to patients during surgical and medical procedures
0.002 0.998 0.000
F33 Recurrent depressive disorder
0.002 0.998 0.000
N75 Diseases of Bartholin's gland
0.001 0.998 0.001
X67 Intentional self-poisoning by and exposure to other gases and vapours
0.002 0.998 0.000
X65 Intentional self-poisoning by and exposure to alcohol
0.002 0.998 0.000
Y59 Other and unspecified vaccines and biological substances
0.002 0.998 0.000
X63.9 Unspecified place
0.001 0.998 0.000
X63.8 Other specified place
0.001 0.998 0.000
X63.7 Farm
0.001 0.998 0.000
X63.6 Industrial and construction area
0.001 0.998 0.000
X63.5 Trade and service area
0.001 0.998 0.000
X63.4 Street and highway
0.001 0.998 0.000
X63.3 Sports and athletics area
0.001 0.998 0.000
X63.2 School, other institution and public administrative area
0.001 0.998 0.000
X63.1 Residential institution
0.001 0.998 0.000
V44 Car occupant injured in collision with heavy transport vehicle or bus
0.002 0.998 0.000
V43 Car occupant injured in collision with car, pick-up truck or van
0.002 0.998 0.000
X84 Intentional self-harm by unspecified means
0.001 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.